9 Einträge gefunden

1. Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer.

   1. Schütze, Dina
   2. Wölber, Linn
   3. Jung, Sabine
   4. Zu Eulenburg, Christine Gräfin
   5. Choschzick, Matthias
   6. Witzel, Isabell
   7. Schwarz, Jörg

   2011 - Forschungsinformationssystem des UKE
2. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Wirtz, Ralph M
   4. Roth, Claudia
   5. Henningsen, Maike
   6. Mahner, Sven
   7. Zu Eulenburg, Christine Gräfin

   2010 - Forschungsinformationssystem des UKE
3. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

   1. Henningsen, Maike
   2. Wirtz, R M
   3. Kalogeras, K T
   4. Milde-Langosch, Karin
   5. Schmidt, M
   6. Witzel, Isabell
   7. Eleftheraki, A G

   2010 - Forschungsinformationssystem des UKE
4. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

   1. Henningsen, Maike
   2. Köhler, N
   3. Kersten, Jan Felix
   4. Milde-Langosch, Karin
   5. Beck, K
   6. Höller, S
   7. Müller, Volkmar

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
5. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.

   1. Henningsen, Maike
   2. Müller, Volkmar
   3. Wirtz, R M
   4. Schröder, Christine
   5. Krenkel, S
   6. Witzel, Isabell
   7. Lisboa, B W

   2008 - Forschungsinformationssystem des UKE
6. Trastuzumab in pregnancy associated with poor fetal outcome.

   1. Witzel, Isabell
   2. Müller, Volkmar
   3. Harps, E
   4. Jänicke, Fritz
   5. De Wit, Maike

   2008 - Forschungsinformationssystem des UKE
7. Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.

   1. Müller, Volkmar
   2. Witzel, Isabell
   3. Pantel, Klaus
   4. Krenkel, Sylke
   5. Lück, Hans Joachim
   6. Neumann, Rainer
   7. Keller, Thomas

   2006 - Forschungsinformationssystem des UKE
8. Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer.

   1. Witzel, Isabell
   2. Thomssen, C
   3. Krenkel, S
   4. Wilczak, Waldemar
   5. Bubenheim, M
   6. Pantel, K
   7. Neumann, R

   2006 - Forschungsinformationssystem des UKE
9. Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

   1. Müller, Volkmar
   2. Witzel, Isabell
   3. Lück, Hans Joachim
   4. Köhler, Günter
   5. von Minckwitz, Gunther
   6. Möbus, Volker
   7. Sattler, Daniel

   2004 - Forschungsinformationssystem des UKE